Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
5 Great Home Remodel Administrations With Green Arrangements In 2024- The Most Enrapturing Authentic Milestones to Visit
- Make your choice for the PS5 game that you love playing with companions!
- Lebanon’s Hezbollah and Yemen’s Houthis join Iran in strike on Israel
- Space Condos to Lift Your Metropolitan Living
- Thousands of New York City nurses set to strike Monday if deal isn't reached with hospitals
- Fundamental Home Exercise center Hardware: Amplify Your Exercises
- Exclusive new photos from 'Michael' biopic show Jaafar Jackson as King of Pop
- Steven Spielberg's 'Disclosure Day' trailer drops: What we know about the alien movie
